These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30431436)

  • 1. Relationship of epigenetic variability of miR-124 to extracellular matrix remodelling and age-related MMP-3 expression in rheumatoid arthritis.
    Pávková Goldbergová M; Lipková J; Fedorko J; Němec P; Gatterová J; Válková L; Ševčíková J; Vašků A
    Gen Physiol Biophys; 2018 Sep; 37(6):703-710. PubMed ID: 30431436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of IL-6, IL-13 and IL-15 gene polymorphisms to the rheumatoid factors, anti-CCP and other measures of rheumatoid arthritis activity.
    Pavkova Goldbergova M; Nemec P; Lipkova J; Jarkovsky J; Gatterova J; Ambrozkova D; Vasku A; Soucek M; Pavek N
    Int J Immunogenet; 2014 Feb; 41(1):34-40. PubMed ID: 23773307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
    Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G
    Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
    Jin YJ; Sun L; Yang L; Xing R; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-522 Modulated the Expression of Proinflammatory Cytokines and Matrix Metalloproteinases Partly via Targeting Suppressor of Cytokine Signaling 3 in Rheumatoid Arthritis Synovial Fibroblasts.
    Wang X; Si X; Sun J; Yue L; Wang J; Yu Z
    DNA Cell Biol; 2018 Apr; 37(4):405-415. PubMed ID: 29394098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of serum matrix metalloproteinase-3 in evaluating joint destruction and therapeutic effect in rheumatoid arthritis patients].
    Li L; Cai B; Liao J; Yang B; Huang Z; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):966-9. PubMed ID: 24011160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA‑221 decreases migration and invasion in fibroblast‑like synoviocytes in rheumatoid arthritis.
    Yang S; Yang Y
    Mol Med Rep; 2015 Aug; 12(2):2395-401. PubMed ID: 25891943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Topics on immunological tests for rheumatoid arthritis].
    Kumagai S; Nishimura K; Hayashi N
    Rinsho Byori; 2004 Oct; 52(10):836-43. PubMed ID: 15624500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-210 and miR-155 expression levels as novel biomarkers for rheumatoid arthritis diagnosis.
    Abdul-Maksoud RS; Sediq AM; Kattaia A; Elsayed W; Ezzeldin N; Abdel Galil SM; Ibrahem RA
    Br J Biomed Sci; 2017 Oct; 74(4):209-213. PubMed ID: 28782994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1,25-(OH)2D3 on Proliferation of Fibroblast-Like Synoviocytes and Expressions of Pro-Inflammatory Cytokines through Regulating MicroRNA-22 in a Rat Model of Rheumatoid Arthritis.
    Fan P; He L; Hu N; Luo J; Zhang J; Mo LF; Wang YH; Pu D; Lv XH; Hao ZM; Ding CH; Xue WJ; Li Y
    Cell Physiol Biochem; 2017; 42(1):145-155. PubMed ID: 28528333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
    Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
    Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the 5A/6A promoter polymorphism of the MMP-3 gene with the radiographic progression of rheumatoid arthritis.
    Nemec P; Pavkova-Goldbergova M; Gatterova J; Vasku A; Soucek M
    Ann N Y Acad Sci; 2007 Sep; 1110():166-76. PubMed ID: 17911432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA rheumatoid factor as a serological predictor of poor response to tumour necrosis factor α inhibitors in rheumatoid arthritis.
    Sakthiswary R; Shaharir SS; Mohd Said MS; Asrul AW; Shahril NS
    Int J Rheum Dis; 2014 Nov; 17(8):872-7. PubMed ID: 25292482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.